Wait & watchFrom ATH ($0.195c) in June 2021, it retraced to 61.8%fib zone around $0.08c. Since then it has recovered some lost ground making higher lows. $0.11c is strong historical S/R zone but a break & close above that will potentially be bullish
−0.0040EUR
−6.57 MEUR
1.98 B
About ACTINOGEN MEDICAL LTD.
Sector
CEO
Steven G. Gourlay
Headquarters
Sydney
Website
Founded
1999
ISIN
AU000000ACW3
FIGI
BBG000TKCFJ6
Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments or cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol. The company was founded by Geoff E. D. Brooke & David Keast on March 23, 1999 and is headquartered in Sydney, Australia.
Shares in ACW are this morning trading up over 200%Shares in ACW are this morning trading up over 200% from their closing price yesterday. The company released an update regarding their Xanamem product.
The key points the company focused on in the release were.
- Statistically significant results demonstrate cognitive improvement in healthy elderl
ACW UpdateOn the daily and weekly both charts on the MACD show some south ,movement while I was pasting up the head and shoulders.
I will be looking for a good buy in a day or two to jump on the ride north as soon as MACD start to show a change.
Looking for Tips and education so feel free to comment.
ACWI've been watching this one for a very little one waiting for some news.
- News drop and bull pushed and found some resistance at 5c.
- after over a week it looks to me as resistance has thinned out.
I think we are on a new upward trend
ACW confirms reversalFollowing on from the reversal setup a few days ago, ACW has confirmed the reversal with a higher low. Should see continued rise, albeit slowly, driven by improving FA and expectation of trial results and updates.
ACW clear breakout on VolumeA very clear breakout on volume for ACW today. Looks like selling has eased off. Should push higher on sustained volume. look for a confirmation in coming days. Good FA behind this one.
ACW possible reversal.ACW has put in the early stages of a reversal. Low rejected on good volume. Next few days will confirm this possible reversal. Good FA and expectation of results mid year should provide a good catalyst.
It appears some value is being seen at current share price. Interesting one to follow.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ACTINOGEN MEDICAL LTD. stocks are traded under the ticker 3AC.
ACTINOGEN MEDICAL LTD. is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track ACTINOGEN MEDICAL LTD. financials in yearly and quarterly reports right on TradingView.
3AC net income for the last quarter is −7.13 M EUR, while the quarter before that showed −2.02 M EUR of net income which accounts for −252.31% change. Track more ACTINOGEN MEDICAL LTD. financial stats to get the full picture.
No, 3AC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 3AC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ACTINOGEN MEDICAL LTD. stock right from TradingView charts — choose your broker and connect to your account.